5 results
To evaluate the safety and clinical performance of the LCP system in patients who are indicated for VVI(R) pacemaker.
The purpose of this study is to explore the efficacy and safety of LTP001 in participants with WHO Group 1 pulmonary hypertension (PH), also referred to as Pulmonary Arterial Hypertension (PAH).This proof of concept study will be executed as the…
The main goal of this study is to determine whether the CGM can replace venipunctures to measure blood glucose values during the oGTT.The second goal of this study is to investigate to what extent glucose profiles, measured at home using the CGM,…
To assess the long term safety of LTP001 in participants with pulmonary arterial hypertension (PAH).
The purpose of the study is to look at how well the study treatment works in participants with idiopathic pulmonary fibrosis.